All In Biotech

NDA 017863 · Baxter Hlthcare

Sorbitol 3% In Plastic Container

Sorbitol · Irrigation

Last checked: Nov 20, 2026Latest source record: Mar 23, 2004 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1980

May 30, 1980

Approved uses

1

Original approval plus efficacy supplements

Registered trials

150

46 Phase 3, 17 recruiting

FAERS reports

603

517 serious, 118 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Dec 31, 2019.

INDICATIONS AND USAGE 3% Sorbitol Urologic Irrigating Solution is indicated for use as a urologic irrigating fluid with endoscopic instruments during transurethral procedures requiring distension, irrigation, and lavage of the urinary bladder. It may be used for lavage of an indwelling catheter to maintain patency.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • May 30, 1980 Original approval · Type 5 - New Formulation or New Manufacturer
1 products under this application
  • SORBITOL 3% IN PLASTIC CONTAINER · SORBITOL 3GM/100ML · SOLUTION, IRRIGATION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Sorbitol" as an intervention, any sponsor and status, largest first.

All 150 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • vomiting44
  • nausea43
  • diarrhoea41
  • constipation38
  • acute kidney injury36
  • fatigue36
  • pain36
  • asthenia32
  • chronic kidney disease32
  • fall32
  • renal failure29
  • hypotension28

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200432
200543
200612
200713
200815
200927
201020
201117
201217
201328
201430
201527
201636
201731
201847
201938
202034
202141
202220
202319
202421
202516
202619

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 339 on PubMed

Sponsor: Baxter Hlthcare

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.